Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Nektar Therapeutics (NQ: NKTR)
9.270 USD  -0.035 (-0.38%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Nektar Therapeutics
 
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
NKTR Crosses Below Key Moving Average Level
May 22, 2013
In trading on Wednesday, shares of Nektar Therapeutics (NKTR) crossed below their 200 day moving average of $9.06, changing hands as low as $9.05 per share. Nektar Therapeutics shares are currently... Read More
category Stocks
from Market News Video
Nektar Therapeutics Earnings Hindsight: Down 1.4% in Last 11 Days (NKTR)
May 20, 2013
from Comtex SmarTrend® News Briefs
Nektar Therapeutics Enters Oversold Territory (NKTR)
May 10, 2013
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... Read More
category Stocks
from Market News Video
Nektar Therapeutics (NKTR) Misses Q1 EPS by 6c, Sales Rise
May 09, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8323859 for the full story. Read More
from StreetInsider.com News Articles
55.5% Return Seen to Date on SmarTrend Nektar Therapeutics Call (NKTR)
April 30, 2013
from Comtex SmarTrend® News Briefs
Uptrend Call Working As Nektar Therapeutics Stock Rises 53.6% (NKTR)
April 22, 2013
from Comtex SmarTrend® News Briefs
Nektar Therapeutics Up 49.5% Since SmarTrend Uptrend Call (NKTR)
April 15, 2013
from Comtex SmarTrend® News Briefs
Nektar Therapeutics Shares Up 47.4% Since SmarTrend's Buy Recommendation (NKTR)
April 08, 2013
from Comtex SmarTrend® News Briefs
Uptrend Call Working As Nektar Therapeutics Stock Rises 53.8% (NKTR)
April 01, 2013
from Comtex SmarTrend® News Briefs
7 Big Growth Stories in Biotech: Keith Markey
March 29, 2013
category Pharmaceuticals
from Trefis
7 Big Growth Stories in Biotech: Keith Markey
March 28, 2013
7 Big Growth Stories in Biotech: Keith Markey Source: George S. Mack of The Life Sciences Report (3/28/13) http://www.thelifesciencesreport.com/pub/na/15108 As a former biotechnology researcher and... Read More
category RXII , NKTR , NVLT , and 9 more.
from Bio-Wire.Com
MKM Partners Reiterates Bullish Stance on Nektar Therapeutics (NKTR); Phase 3 to Start this Month
March 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8200226 for the full story. Read More
from StreetInsider.com News Articles
Post Earnings Update: Nektar Therapeutics Has Climbed 8.8% Higher in Past 2 Weeks (NKTR)
March 18, 2013
from Comtex SmarTrend® News Briefs
Nektar Therapeutics Up 41.0% Since SmarTrend Uptrend Call (NKTR)
March 14, 2013
from Comtex SmarTrend® News Briefs
Nektar Therapeutics Earnings Review: 11 Days after Announcement Shares Up 8.4% (NKTR)
March 11, 2013
from Comtex SmarTrend® News Briefs
Uptrend Call Working As Nektar Therapeutics Stock Rises 40.0% (NKTR)
March 07, 2013
from Comtex SmarTrend® News Briefs
Nektar Therapeutics (NKTR) Reports Q4 Loss of $0.46
February 28, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8144593 for the full story. Read More
from StreetInsider.com News Articles
30.1% Return Seen to Date on SmarTrend Nektar Therapeutics Call (NKTR)
February 28, 2013
from Comtex SmarTrend® News Briefs
AstraZeneca (AZN) Issues Encouraging Update from High-Level KODIAC-08 Trial
February 26, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8131490 for the full story. Read More
from StreetInsider.com News Articles
BRIEF-AstraZeneca Naloxegol trial shows no imbalances in adverse effects
February 26, 2013
LONDON, Feb 26 (Reuters) - AstraZeneca PLC : * Announces results from long-term safety trial of Naloxegol in patients with Read More
category companyNews
from Reuters: Company News
Earnings Update: Nektar Therapeutics Releases its Quarterly Earnings on February 28th, 2013 (NKTR)
February 25, 2013
from Comtex SmarTrend® News Briefs
Uptrend Call Working As Nektar Therapeutics Stock Rises 26.2% (NKTR)
February 20, 2013
from Comtex SmarTrend® News Briefs
Nektar (NKTR) Commences Etirinotecan Pegol Phase 2 in NSCLC Patients
February 05, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8058992 for the full story. Read More
from StreetInsider.com News Articles
Nektar Therapeutics Has Returned 19.9% Since SmarTrend Recommendation (NKTR)
January 31, 2013
from Comtex SmarTrend® News Briefs
23.3% Return Seen to Date on SmarTrend Nektar Therapeutics Call (NKTR)
January 24, 2013
from Comtex SmarTrend® News Briefs
Nektar Therapeutics Has Returned 28.0% Since SmarTrend Recommendation (NKTR)
January 17, 2013
from Comtex SmarTrend® News Briefs
Notable Analyst Rating Changes 01/15: (VPHM) (BSX) (GMCR) Upgraded; (HL) (ARMH) (AMTD) Downgraded
January 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8009131 for the full story. Read More
from StreetInsider.com News Articles
Lazard Capital Starts Nektar Therapeutics (NKTR) at Buy
January 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8007730 for the full story. Read More
from StreetInsider.com News Articles
Nektar Therapeutics - Market Recap
January 15, 2013
NEW YORK (AVAFIN) -- Nektar Therapeutics options set a new 90-day record for the ... Read More
from AVAFIN
NKTR Makes Bullish Cross Above Critical Moving Average
January 09, 2013
In trading on Wednesday, shares of Nektar Therapeutics (NKTR) crossed above their 200 day moving average of $8.07, changing hands as high as $8.40 per share. Nektar Therapeutics shares are currently... Read More
category Stocks
from Market News Video
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here